|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Sen GL and Blau HM: A brief history of
RNAi: the silence of the genes. FASEB J. 20:1293–1299. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Katoh M and Katoh M: Identification and
characterization of JMJD2 family genes in silico. Int J
Oncol. 24:1623–1628. 2004.PubMed/NCBI
|
|
4
|
Gray SG, Iglesias AH, Lizcano F,
Villanueva R, Camelo S, Jingu H, Teh BT, Koibuchi N, Chin WW,
Kokkotou E and Dangond F: Functional characterization of JMJD2A, a
histone deacetylase- and retinoblastoma-binding protein. J Biol
Chem. 280:28507–28518. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shin S and Janknecht R: Activation of
androgen receptor by histone demethylases JMJD2A and JMJD2D.
Biochem Biophys Res Commun. 359:742–746. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Trojer P and Reinberg D: Histone lysine
demethylases and their impact on epigenetics. Cell. 125:213–217.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Whetstine JR, Nottke A, Lan F, Huarte M,
Smolikov S, Chen Z, Spooner E, Li E, Zhang G, Colaiacovo M and Shi
Y: Reversal of histone lysine trimethylation by the JMJD2 family of
histone demethylases. Cell. 125:467–481. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nottke A, Colaiácovo MP and Shi Y:
Developmental roles of the histone lysine demethylases.
Development. 136:879–889. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang XD, Wang Y, Wang Y, Zhang X, Han R,
Wu JC, Liang ZQ, Gu ZL, Han F, Fukunaga K and Qin ZH: p53 mediates
mitochondria dysfunction-triggered autophagy activation and cell
death in rat striatum. Autophagy. 5:339–350. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Luo CL, Li BX, Li QQ, Chen XP, Sun YX, Bao
HJ, Dai DK, Shen YW, Xu HF, Ni H, et al: Autophagy is involved in
traumatic brain injury-induced cell death and contributes to
functional outcome deficits in mice. Neuroscience. 184:54–63. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dai HY, Liu L, Qin SK, He XM and Li SY:
Lobaplatin suppresses proliferation and induces apoptosis in the
human colorectal carcinoma cell Line LOVO in vitro. Biomed
Pharmacother. 65:137–141. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tang Y, Huang B, Sun L, Peng X, Chen X and
Zou X: Ginkgolide B promotes proliferation and functional
activities of bone marrow-derived endothelial progenitor cells:
involvement of Akt/eNOS and MAPK/p38 signaling pathways. Eur Cell
Mater. 21:459–69. 2011.
|
|
13
|
Li L, Zhang C, Li X, Lu S and Zhou Y: The
candidate tumor suppressor gene ECRG4 inhibits cancer cells
migration and invasion in esophageal carcinoma. J Exp Clin Cancer
Res. 29:1332010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jovanovic J, Rønneberg JA, Tost J and
Kristensen V: The epigenetics of breast cancer. Mol Oncol.
4:242–254. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Martin C and Zhang Y: The diverse
functions of histone lysine methylation. Nat Rev Mol Cell Biol.
6:838–849. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Müller-Tidow C, Klein HU, Hascher A, Isken
F, Tickenbrock L, Thoennissen N, Agrawal-Singh S, Tschanter P,
Disselhoff C, Wang Y, Becker A, Thiede C, Ehninger G, zur Stadt U,
Koschmieder S, Seidl M, Müller FU, Schmitz W, Schlenke P,
McClelland M, Berdel WE, Dugas M and Serve H; Study Alliance
Leukemia: Profiling of histone H3 lysine 9 trimethylation levels
predicts transcription factor activity and survival in acute
myeloid leukemia. Blood. 116:3564–3571. 2010.
|
|
17
|
Cloos PA, Christensen J, Agger K and Helin
K: Erasing the methyl mark: histone demethylases at the center of
cellular differentiation and disease. Genes Dev. 22:1115–1140.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schübeler D, MacAlpine DM, Scalzo D,
Wirbelauer C, Kooperberg C, van Leeuwen F, Gottschling DE, O’Neill
LP, Turner BM, Delrow J, Bell SP and Groudine M: The histone
modification pattern of active genes revealed through genome-wide
chromatin analysis of higher eukaryote. Genes Dev. 18:1263–1271.
2004.PubMed/NCBI
|
|
19
|
Shilatifard A: Chromatin modifications by
methylation and ubiquitination: implications in the regulation of
gene expression. Annu Rev Biochem. 75:243–269. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu D, Bai J, Duan Q, Costa M and Dai W:
Covalent modifications of histones during mitosis and meiosis. Cell
Cycle. 8:3688–3694. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mikkelsen TS, Ku M, Jaffe DB, Issac B,
Lieberman E, Giannoukos G, Alvarez P, Brockman W, Kim TK, Koche RP,
et al: Genome-wide maps of chromatin state in pluripotent and
lineage-committed cells. Nature. 448:553–560. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Barski A, Cuddapah S, Cui K, Roh TY,
Schones DE, Wang Z, Wei G, Chepelev I and Zhao K: High-resolution
profiling of histone methylations in the human genome. Cell.
129:823–837. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brinkman AB, Roelofsen T, Pennings SW,
Martens JH, Jenuwein T and Stunnenberg HG: Histone modification
patterns associated with the human X chromosome. EMBO Rep.
7:628–634. 2006.PubMed/NCBI
|
|
24
|
Vakoc CR, Mandat SA, Olenchock BA and
Blobel GA: Histone H3 lysine 9 methylation and HP1gamma are
associated with transcription elongation through mammalian
chromatin. Mol Cell. 19:381–391. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gomes NP and Espinosa JM: Gene-specific
repression of the p53 target gene PUMA via intragenic CTCF-Cohesin
binding. Genes Dev. 24:1022–1034. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Peters AH, O’Carroll D, Scherthan H,
Mechtler K, Sauer S, Schöfer C, Weipoltshammer K, Pagani M, Lachner
M, Kohlmaier A, et al: Loss of the Suv39h histone
methyltransferases impairs mammalian heterochromatin and genome
stability. Cell. 107:323–337. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Braig M, Lee S, Loddenkemper C, Rudolph C,
Peters AH, Schlegelberger B, Stein H, Dörken B, Jenuwein T and
Schmitt CA: Oncogene-induced senescence as an initial barrier in
lymphoma development. Nature. 436:660–665. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kawazu M, Saso K, Tong KI, McQuire T, Goto
K, Son DO, Wakeham A, Miyagishi M, Mak TW and Okada H: Histone
demethylase JMJD2B functions as a co-factor of estrogen receptor in
breast cancer proliferation and mammary gland development. PLoS
One. 6:e178302011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Takaki T, Fukasawa K, Suzuki-Takahashi I
and Hirai H: Cdk-mediated phosphorylation of pRB regulates HDAC
binding in vitro. Biochem Biophys Res Commun. 316:252–255.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lai A, Kennedy BK, Barbie DA, Bertos NR,
Yang XJ, Theberge MC, Tsai SC, Seto E, Zhang Y, Kuzmichev A, et al:
RBP1 recruits the mSIN3-histone deacetylase complex to the pocket
of retinoblastoma tumor suppressor family proteins found in limited
discrete regions of the nucleus at growth arrest. Mol Cell Biol.
21:2918–2932. 2001. View Article : Google Scholar
|
|
31
|
Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A,
Hunt KK, Helin K, Liao WS and Yu Y: E2F-HDAC complexes negatively
regulate the tumor suppressor gene ARHI in breast cancer. Oncogene.
25:230–239. 2006.PubMed/NCBI
|
|
32
|
Yu Y, Xu F, Peng H, Fang X, Zhao S, Li Y,
Cuevas B, Kuo WL, Gray JW, Siciliano M, Mills GB and Bast RC Jr:
NOEY2 (ARHI), an imprinted putative tumor suppressor gene in
ovarian and breast carcinomas. Proc Natl Acad Sci USA. 96:214–219.
1999. View Article : Google Scholar : PubMed/NCBI
|
